Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: MYLK4 promotes tumor progression through the activation of epidermal growth factor receptor signaling in osteosarcoma

Fig. 1

MYLK4 is upregulated in metastatic human OS tissues. a The expression of MYLK4 in non-metastasis and metastasis OS samples in TARGET database. Statistically significant differences (t-test), *P < 0.05. b Immunohistochemistry analyses of MYLK4 expression levels in 8 paired metastatic human OS and non-metastatic human OS tissues. Statistically significant differences (t-test), **P < 0.01. c Representative immunohistochemical assays of MYLK4 expression in metastatic human OS (down) and non-metastatic human OS tissues (up). d Western blot analysis of MYLK4 expression in metastatic human OS compared with non-metastatic human OS tissues. e-f KM survival curves for overall survival and event-free survival of osteosarcoma patients from MYLK4-high and MYLK4-low groups

Back to article page